TAIPEI APASL 2023 

Reaching New Heights: 
Strengthening Commitment to Patients with Viral Hepatitis

 
Saturday, 18th February 2023 |17:40–19:00 (TST)
 
Room 201ABC, 2F, Taipei International Convention Center

Dear Colleagues,

It is with great pleasure that I invite you to the Gilead Sciences satellite symposium ‘Reaching New Heights: Strengthening Commitment to Patients with Viral Hepatitis’.

Despite significant progress in the treatment of viral hepatitis in the Asia-Pacific region in recent years, many unmet needs remain.1 In this symposium, our expert faculty will discuss considerations regarding early HBV treatment initiation, as well as HCV elimination progress with future directions. Lastly, we will explore recent advances in the treatment landscapes of viral hepatitis, how collaborative efforts are required to overcome remaining challenges in the Asia-Pacific region, and how we can strive to further improve the lives of patients.

On behalf of the faculty, I look forward to your participation in this engaging and educational symposium.

Prof. Jia-Horng Kao
Symposium Chair


Faculty Members and Agenda

Prof. Jia-Horng Kao
(Chair; Taipei)
Prof. Young-Suk Lim
(Seoul)
Prof. Nancy Reau
(Chicago)
Dr. Catherine Frenette
(San Diego)

10 min
Welcome and Opening Remarks

20 min
Early Treatment in HBV
20 min
HCV Elimination Efforts
20 min
Collaborative Efforts and Commitment to Liver Disease

10 min
Closing Remarks
1. Le LV, et al. Liver Int. 2022;42(9):1930-1934.
This non-promotional meeting is organized by Gilead Sciences Hong Kong Limited Taiwan Branch.
Date of preparation: February 2023. HK-UNB-0187_v1.0_03Feb2023 © 2023 Gilead Sciences Hong Kong Limited Taiwan Branch
This website is non-promotional and intended to provide scientific information to healthcare professionals. The content provided on this website has undergone strict internal medical review and is regularly updated to reflect new information.
icon_BackToTop